2019
Interstitial Lung Disease Induced by Crizotinib in Non-Small-Cell Lung Cancer
Abstract: The treatment of advanced non-small-cell lung cancer shifted with the development of molecular-targeted therapies, like the tyrosine kinase inhibitors. One example of tyrosine kinase inhibitors is crizotinib, an anaplastic lymphoma tyrosine kinase inhibitor, which targets an echinoderm microtubule-associated protein-like-4-anaplastic lymphoma kinase gene fusion. This mutation is found in only 2% to 7% of non-small-cell lung cancer cases. Although these new therapies have shown promising results, the occurrence…
Search citation statements
Paper Sections
Select...
3
2
0
0
Citation Types
0
4
0
0
Year Published
Range
2019
2022
Publication Types
Select...
5
Relationship
0
5
Authors
Journals
Cited by 5 publications
(4 citation statements)
References 15 publications
0
4
0
0
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Chronic respiratory diseases are one of the leading causes of death globally. Victims of lung disorders frequently experience long-term difficulties, with one of the major causes being treatment side effects as well as psychosocial struggles [17]. Respiratory diseases are characterized by unrestricted cell proliferation and no single defined cause, but they are associated with several risk factors, including tobacco use, infection, radiation exposure, air pollution, obesity, and alcohol consumption.…”
Section: Introduction
mentioning
confidence: 99%